BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Cash on Hand 2023–2025
BridgeBio Oncology Therapeutics, Inc. annual cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BridgeBio Oncology Therapeutics, Inc. cash on hand as of December 31, 2025: 373.7M, a 1111.26% increase year-over-year.
- BridgeBio Oncology Therapeutics, Inc. cash on hand for 2025 were 373.7M, a 1111.26% increase from 2024.
- BridgeBio Oncology Therapeutics, Inc. cash on hand for 2024 were 30.9M, a 12240.40% increase from 2023.
- BridgeBio Oncology Therapeutics, Inc. cash on hand for 2023 were 250,000.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BridgeBio Oncology Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $374 |
| 2024 | $31 |
| 2023 | $0 |
BridgeBio Oncology Therapeutics, Inc. Cash on Hand — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's cash on hand history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.